Vishay Intertechnology Announces 2016 Annual Meeting
Apr 01, 2016 12:30 pm UTC| Business
MALVERN, Pa., April 01, 2016 -- Vishay Intertechnology, Inc., (NYSE:VSH) announced today that its Annual Meeting of Stockholders will be held on Tuesday, May 24, 2016 at 9:30 AM ET at Vishay Intertechnology, Inc., world...
Transcat Expands Presence in Southern California with Acquisition of Excalibur Engineering, Inc.
Apr 01, 2016 12:30 pm UTC| Business
ROCHESTER, N.Y., April 01, 2016 -- Transcat, Inc. (NASDAQ:TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration and compliance services and value-added distributor of professional grade...
Keryx Biopharmaceuticals Announces New Appointments and Changes to its Board of Directors
Apr 01, 2016 12:30 pm UTC| Business
BOSTON, April 01, 2016 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to market for people with renal disease, today announced appointment of two...
MYnd Analytics Receives IRB Approvals for SMART-MD Replication Trial
Apr 01, 2016 12:30 pm UTC| Business
MISSION VIEJO, Calif., April 01, 2016 -- MYnd Analytics, Inc. (OTCQB:CNSO) obtained approval from two Institutional Review Boards to conduct a clinical trial of its Psychiatric EEG Evaluation Registry (PEER) Interactive...
Apr 01, 2016 12:30 pm UTC| Business
SAN FRANCISCO, April 01, 2016 -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts Apollo Education Group Incorporated (NASDAQ:APOL) investors of the May 13, 2016 lead plaintiff deadline in...
Apr 01, 2016 12:30 pm UTC| Business
SAN FRANCISCO, April 01, 2016 -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds IRSA Inversiones y Representaciones S.A. (NYSE:IRS) investors of the April 25, 2016 lead plaintiff deadline...
Diffusion Pharmaceuticals Appoints Thomas Byrne as General Counsel
Apr 01, 2016 12:25 pm UTC| Business
CHARLOTTESVILLE, Va., April 01, 2016 -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therapeutics for cancer, today announced...